<DOC>
	<DOCNO>NCT00654485</DOCNO>
	<brief_summary>The purpose study compare efficacy treatment rosuvastatin atorvastatin reduce Low density lipoprotein cholesterol 6 week treatment subject metabolic syndrome .</brief_summary>
	<brief_title>COMETS - Compare Efficacy Rosuvastatin With Atorvastatin Placebo Treatment Non-Diabetic , Non-Atheroscleric , Metabolic Syndrome Subjects</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Presence 3 coronary heart disease risk factor define protocol . Fasting low density lipoprotein cholesterol level &gt; 130 mg/dL . Documented history , high risk coronary heart disease establish atherosclerotic disease . Not previously take statin . The use lipid lower drug dietary supplement Visit 1 Active arterial disease eg Unstable angina , recent arterial surgery Blood lipid level limit define protocol Uncontrolled hypertension , hypothyroidism , alcohol drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Cholesterol</keyword>
	<keyword>hypercholesterolemia</keyword>
	<keyword>low density lipoprotein</keyword>
	<keyword>metabolic syndrome</keyword>
	<keyword>Rosuvastatin</keyword>
</DOC>